| High PD-L1 expression was associated with poor prognosis in 870 Chinese patients with breast cancer T Qin, Y Zeng, G Qin, F Xu, J Lu, W Fang, C Xue, J Zhan, X Zhang, ... Oncotarget 6 (32), 33972, 2015 | 193 | 2015 |
| The genomic landscape of Epstein-Barr virus-associated pulmonary lymphoepithelioma-like carcinoma S Hong, D Liu, S Luo, W Fang, J Zhan, S Fu, Y Zhang, X Wu, H Zhou, ... Nature communications 10 (1), 3108, 2019 | 89 | 2019 |
| Palbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun/COX-2 signaling pathway G Qin, F Xu, T Qin, Q Zheng, D Shi, W Xia, Y Tian, Y Tang, J Wang, X Xiao, ... Oncotarget 6 (39), 41794, 2015 | 85 | 2015 |
| The prognostic significance of topoisomerase II alpha protein in early stage luminal breast cancer X An, F Xu, R Luo, Q Zheng, J Lu, Y Yang, T Qin, Z Yuan, Y Shi, W Jiang, ... BMC cancer 18, 1-10, 2018 | 84 | 2018 |
| The correlations of tumor mutational burden among single-region tissue, multi-region tissues and blood in non-small cell lung cancer Y Zhang, L Chang, Y Yang, W Fang, Y Guan, A Wu, S Hong, H Zhou, ... Journal for immunotherapy of cancer 7 (1), 98, 2019 | 64 | 2019 |
| Intratumor heterogeneity comparison among different subtypes of non-small-cell lung cancer through multi-region tissue and matched ctDNA sequencing Y Zhang, L Chang, Y Yang, W Fang, Y Guan, A Wu, S Hong, H Zhou, ... Molecular cancer 18 (1), 7, 2019 | 57 | 2019 |
| Clinical value of circulating ESR1 mutations for patients with metastatic breast cancer: a meta-analysis K Zhang, R Hong, F Xu, W Xia, L Kaping, G Qin, Q Zheng, Q Lu, YX Shi, ... Cancer management and research, 2573-2580, 2018 | 45 | 2018 |
| CDK4/6 inhibitor palbociclib enhances the effect of pyrotinib in HER2-positive breast cancer K Zhang, R Hong, L Kaping, F Xu, W Xia, G Qin, Q Zheng, Q Lu, Q Zhai, ... Cancer letters 447, 130-140, 2019 | 40 | 2019 |
| EGFR T790M relative mutation purity predicts osimertinib treatment efficacy in non-small cell lung cancer patients Q Zheng, S Hong, Y Huang, H Zhao, Y Yang, X Hou, Y Zhao, Y Ma, ... Clinical and translational medicine 9, 1-10, 2020 | 20 | 2020 |
| Emergence of EGFR G724S after progression on osimertinib responded to afatinib monotherapy W Fang, Y Huang, J Gan, Q Zheng, L Zhang Journal of Thoracic Oncology 15 (3), e36-e37, 2020 | 19 | 2020 |
| Metronomic chemotherapy of cyclophosphamide plus methotrexate for advanced breast cancer: Real‐world data analyses and experience of one center Q Lu, K Lee, F Xu, W Xia, Q Zheng, R Hong, K Jiang, Q Zhai, Y Li, Y Shi, ... Cancer Communications 40 (5), 222-233, 2020 | 16 | 2020 |
| Selective estrogen receptor modulator-associated nonalcoholic fatty liver disease improved survival in patients with breast Cancer: a retrospective cohort analysis Q Zheng, F Xu, M Nie, W Xia, T Qin, G Qin, X An, C Xue, R Peng, Z Yuan, ... Medicine 94 (40), e1718, 2015 | 15 | 2015 |
| Identification and characterization of critical genes associated with tamoxifen resistance in breast cancer K Zhang, K Jiang, R Hong, F Xu, W Xia, G Qin, K Lee, Q Zheng, Q Lu, ... PeerJ 8, e10468, 2020 | 14 | 2020 |
| Clinical genomic profiling to identify actionable alterations for very early relapsed triple-negative breast cancer patients in the Chinese population L Wang, Q Zhai, Q Lu, K Lee, Q Zheng, R Hong, S Wang Annals of Medicine 53 (1), 1358-1369, 2021 | 12 | 2021 |
| EGFR mutation genotypes affect efficacy and resistance mechanisms of osimertinib in T790M-positive NSCLC patients Q Zheng, Y Huang, H Zhao, Y Yang, S Hong, X Hou, Y Zhao, Y Ma, ... Translational Lung Cancer Research 9 (3), 471, 2020 | 12 | 2020 |
| A single-cell immune atlas of triple negative breast cancer reveals novel immune cell subsets S Qiu, R Hong, Z Zhuang, Y Li, L Zhu, X Lin, Q Zheng, S Liu, K Zhang, ... BioRxiv, 566968, 2019 | 10 | 2019 |
| CPSF4 promotes triple negative breast cancer metastasis by upregulating MDM4 K Lee, Q Zheng, Q Lu, F Xu, G Qin, Q Zhai, R Hong, M Chen, W Deng, ... Signal transduction and targeted therapy 6 (1), 184, 2021 | 7 | 2021 |
| Nomogram model of LNR predicts survival in premenopausal patients with node-positive luminal breast cancer T Qin, YD Zeng, Q Lu, X Zhang, GE Qin, Q Zheng, F Xu, R Peng, Z Yuan, ... Anticancer Research 37 (8), 4575-4586, 2017 | 7 | 2017 |
| Long-term survival after sentinel lymph node biopsy or axillary lymph node dissection in pN0 breast cancer patients: a population-based study Q Zheng, H Luo, W Xia, Q Lu, K Jiang, R Hong, F Xu, S Wang Breast Cancer Research and Treatment 196 (3), 613-622, 2022 | 6 | 2022 |
| Pyrotinib combined with vinorelbine in patients with previously treated HER2-positive metastatic breast cancer: a multicenter, single-arm, prospective study K Jiang, R Hong, W Xia, Q Lu, L Li, J Huang, Y Shi, Z Yuan, Q Zheng, ... Cancer Research and Treatment: Official Journal of Korean Cancer Association …, 2024 | 5 | 2024 |
